Interview with Carlos Mayotti, Commercial Director, Phoenix
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Address: Ave Gen. J. Lemos 2809 (B1614BDH). Villa de Mayo. Buenos Aires. Argentina.
Tel: (54-11) 4489-8300
Web: http://www.phoenix.com.ar/
A Commitment to Health is what characterizes the more than half-a-century of activity carried out by Laboratorios Phoenix, a pioneer in offering to the domestic market the product of state-of-the-art international research, including the first antibiotics and antipoliomyelitic vaccines.
Throughout its trajectory, Laboratorios Phoenix has contributed to the growth of the Argentine pharmaceutical industry, assuring up-to-date scientific dissemination and production of drugs according to the most demanding standards of quality control.
As a licensee, Laboratorios Phoenix has demonstrated in its production an entrepreneurial soundness and scientific rigor in accordance with the standards of important foreign laboratories. And as a result of creative innovation, it has also made its own achievements in the field of leading edge research, developing state-of-the art technology in the area of oral drug delivery and controlled drug release.
Opthamology, Dermatology, Neurological, Respiratory
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
KPMG’s lead healthcare consultant in Argentina gives an in-depth analysis of the long-term needs and objectives driving change in the industry, the structural issues that need to be overcome before…
The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader…
Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry in Argentina and the region at BioArgentina 2014, an event…
Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the…
Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical…
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations. How did you become part of Glenmark,…
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
See our Cookie Privacy Policy Here
